Walk into any European dispensary or grow shop and the first question you get is: are you looking for Indica or Sativa? The answer determines whether you walk out with a “couch” variety or a “creative” one. The problem is that this distinction — used by millions of people every day — has a far shakier scientific foundation than it appears.

This article brings together the real data: what genomics says, what effect studies demonstrate, why terpenes matter more than the label, and what “hybrid” actually means when almost all modern cannabis already is one.

The Origin of the Debate: Linnaeus vs Lamarck

The current cannabis classification traces back to the eighteenth century and two botanists with opposing perspectives. In 1753, Carl Linnaeus classified the plant as Cannabis sativa L. in his Species Plantarum. Thirty-two years later, Jean-Baptiste Lamarck described a second species, Cannabis indica, in his Encyclopédie Méthodique (1785), based on specimens from India that he found morphologically distinct from European plants: shorter, more branched, with broader leaves.

That initial distinction generated more than two centuries of unresolved scientific debate. Today there are three positions in the literature:

• Monotypic framework: The entire Cannabis genus is a single species (Cannabis sativa L.) with varieties. Favoured by the majority of current molecular geneticists.
• Polytypic framework: The genus contains two or three distinct species. Historically popular among cultivators and classical taxonomists.
• Intermediate framework: One species with subspecies (Cannabis sativa subsp. indica). Common in the pharmaceutical literature.

The Study That Changed Everything: Sawler et al. 2015

The most influential genomic analysis in the modern taxonomic debate was published in PLOS ONE by researchers at Dalhousie University (PMID: 26308334). They applied Genotyping by Sequencing (GBS) to 81 recreational/medicinal cannabis samples and 43 industrial hemp samples, detecting 14,031 SNPs (single nucleotide polymorphisms) distributed across the entire genome.

The most surprising finding: industrial hemp is genetically more similar to Indica-type varieties than to Sativa-type varieties in terms of overall genomic structure. The Indica/Sativa distinction in the market reflects the history of cultivation and human selective pressure more than real biological speciation.

A subsequent study in Nature Plants (October 2021, DOI: 10.1038/s41477-021-01003-y) analysed more than 100 samples with more than 100,000 SNPs and concluded that “samples labelled as Sativa and Indica are genetically indistinguishable at the global genomic scale.” The only detectable genetic differences were associated with variations in terpenoid synthase genes — not with the pharmacological effects attributed to each type.

Morphological Differences: What Is Real

The physical differences between classic phenotypes are measurable and real. What they are not is predictors of pharmacological effects:

The Great Myth Debunked: Indica ≠ More CBD

The belief that “Indica has more CBD and less THC” while “Sativa has more THC and less CBD” is scientifically incorrect.

A study in Frontiers in Pharmacology (2022, DOI: 10.3389/fphar.2022.921493) that analysed a large sample of the US market found that products labelled as Indica and Sativa were chemically intermingled: it was impossible to predict the THC:CBD ratio from the category label.

Dr. Ethan Russo, neurologist and one of the most cited cannabinoid researchers in the world, summed it up in 2016: “The sativa/indica distinction as applied in the popular literature is total nonsense and an exercise in futility.”

Terpenes: The True Architects of Effect

Terpenes are what drive the effect. The most transformative paper for understanding this is Russo (2011) in the British Journal of Pharmacology (PMID: 21749363, 304+ citations), which formalised the concept of the entourage effect applied to phytocannabinoids and terpenoids. We have a full guide on the Entourage Effect.

Terpenes — responsible for aroma and flavour — act as modulators of THC and CBD. They represent only 1% of total cannabis weight but 10% of the weight inside the trichome, the secretory structure where cannabinoids are produced.

Want to learn more about how terpenes work? We have a dedicated article: Cannabis terpenes: types and effects according to science.

Real Effects: What Does the Research Say?

The couch-lock has a name: it's called myrcene

Deep sedation does not come from being “Indica.” It comes from strains with a high myrcene load in combination with THC, regardless of morphological classification. A Sativa high in myrcene can be equally sedating. An Indica low in myrcene will not be.

The energising head high comes from the terpene profile, not the DNA

Energy, creativity, and racing thoughts we associate with Sativas result from profiles with dominant limonene, alpha-pinene, and/or terpinolene. These compounds act on serotonergic and cholinergic receptors, producing alertness and anxiety reduction.

Hybrids: The Truth Nobody Tells You

When someone talks about a “70% Sativa / 30% Indica” strain, what does that actually mean? Practically nothing verifiable.

True landrace strains — non-hybridised regional populations cultivated in their place of origin for generations — are extremely rare in the modern market. Although more than 1,800 strains in commercial catalogues reference “landrace,” genetically uncontaminated pure populations are a minimal fraction, available mainly through genetic preservation projects by specialist breeders.

The commercial market has converged on a narrow genetic pool. OG Kush, Chemdawg, Skunk #1, and their descendants dominate the western catalogue. Contemporary cannabis may be marketed as “60% Indica / 40% Sativa,” but these percentages have no verifiable genomic basis: they are subjective estimates based on morphology and declared lineage.

How to Actually Choose: The Chemotype System

The scientific community is converging on a classification system by chemotype, based on real chemistry, not morphology:

But the THC:CBD ratio is only the first filter. The second — and often more decisive for the experience — is the terpene profile. A chemotype I with dominant myrcene will give a very different result to one with dominant terpinolene, even if both have 20% THC. See our guide on the endocannabinoid system and CBD vs THC.

Well-Known Strains: Real Terpene Profiles

The Scientific Controversy: The System Is Breaking Down

Pressure to reform the Indica/Sativa classification system is coming from multiple scientific fronts:

Nature Plants 2021 concludes that “the sativa-indica scale currently used to label cannabis poorly captures global genomic and metabolomic variation” and recommends producers display terpene profiles instead of morphological labels.

ACS Omega 2024 (American Chemical Society) reinforces that real chemical differentiation between strains lies in total chemical composition, not the morphological label.

McPartland (2018) in Cannabis Cannabinoid Res. proposes maintaining Cannabis as a monotypic genus in his comprehensive taxonomic review.

EUDA (European Union Drugs Agency, successor to the EMCDDA since 2023) does not classify cannabis by Indica/Sativa in its epidemiological reports. Its European Drug Report 2024 highlights that average THC content in cannabis resin has doubled over 10 years, reaching 22.8% in 2022 — evidence that modern selective pressure maximises THC without correspondence to the traditional morphological label.

Frequently Asked Questions